| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Xu B et al. | Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells. | 2007 | Maturitas | pmid:16962266 |
| Oosterbaan HP et al. | The effects of continuous combined transdermal oestrogen-progestogen treatment on bleeding patterns and the endometrium in postmenopausal women. | 1995 | Maturitas | pmid:7616870 |
| Boon J et al. | Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT. | 2003 | Maturitas | pmid:12963171 |
| Høvik P et al. | Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms. | 1989 | Maturitas | pmid:2498620 |
| Nordin BE et al. | A placebo-controlled trial of ethinyl oestradiol and norethisterone in climacteric women. | 1980 | Maturitas | pmid:7003315 |
| Cornu C et al. | Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial. | 2000 | Maturitas | pmid:11137328 |
| Goudev A et al. | Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. | 2002 | Maturitas | pmid:12270582 |
| Tatsumi H et al. | Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. | 2002 | Maturitas | pmid:12191851 |
| Eiken P and Kolthoff N | Compliance with long-term oral hormonal replacement therapy. | 1995 | Maturitas | pmid:8538490 |
| Mueck AO et al. | Impact of hormone replacement therapy on endogenous estradiol metabolism in postmenopausal women. | 2002 | Maturitas | pmid:12385856 |
| Norris LA et al. | Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy. | 2002 | Maturitas | pmid:12385861 |
| Brynhildsen J and Hammar M | Lipids and clotting factors during low dose transdermal estradiol/norethisterone use. | 2005 | Maturitas | pmid:15780536 |
| Li C et al. | Effects of norethisterone acetate addition to estradiol in long term HRT. | 2000 | Maturitas | pmid:11006501 |
| Staland B | Absorption of an oestrogen-progestogen preparation. | 1983 | Maturitas | pmid:6633271 |
| Nathorst-Böös J and Hammar M | Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. | 1997 | Maturitas | pmid:9032742 |
| Silfverstolpe G et al. | Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens. | 1982 | Maturitas | pmid:6811837 |
| Yilmazer M et al. | Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women. | 2003 | Maturitas | pmid:14625121 |
| Haapasaari KM et al. | Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. | 1997 | Maturitas | pmid:9255750 |
| Alfie J et al. | Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate. | 1997 | Maturitas | pmid:9255751 |
| Ruan X et al. | The pharmacology of dienogest. | 2012 | Maturitas | pmid:22364708 |
| Stadberg E et al. | Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausal women. | 1999 | Maturitas | pmid:10585174 |
| Christodoulakos G et al. | Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. | 2005 | Maturitas | pmid:15780533 |
| Lambrinoudaki IV et al. | Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. | 2008 | Maturitas | pmid:18164562 |
| Gruber DM et al. | Endometrial cancer after combined hormone replacement therapy. | 1999 | Maturitas | pmid:10340283 |
| Ranta V et al. | National differences in lipid response to postmenopausal hormone replacement therapy. | 2002 | Maturitas | pmid:12191848 |
| Posaci C et al. | The values of urinary NTx in postmenopausal women undergoing HRT; the role of additional alendronate therapy. | 2002 | Maturitas | pmid:12191850 |
| Loh FH et al. | The efficacy of two dosages of a continuous combined hormone replacement regimen. | 2002 | Maturitas | pmid:11836043 |
| Staland B | Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. | 1981 | Maturitas | pmid:7026979 |
| Fernandes CE et al. | Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow. | 2008 | Maturitas | pmid:18359175 |
| Odmark IS et al. | Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins. | 2004 | Maturitas | pmid:15172088 |
| Albertazzi P et al. | The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study. | 2000 | Maturitas | pmid:11063905 |
| Magos AL et al. | Endometrial and menstrual response to subcutaneous oestradiol and testosterone implants and continuous oral progestogen therapy in post-menopausal women. | 1985 | Maturitas | pmid:4079826 |
| Kwok S et al. | Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women. | 2006 | Maturitas | pmid:16139447 |
| Wiklund I et al. | Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. | 1992 | Maturitas | pmid:1508062 |
| Zhou J et al. | Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. | 2013 | Maturitas | pmid:23856385 |
| Bassol S et al. | The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women. | 2005 | Maturitas | pmid:15734600 |
| Oguz S et al. | The role of hormone replacement therapy in endometrial polyp formation. | 2005 | Maturitas | pmid:15734604 |
| Junkermann H et al. | Influence of different HRT regimens on mammographic density. | 2005 | Maturitas | pmid:15653007 |
| al-Azzawi F et al. | Investigation of the bleeding patterns of postmenopausal women treated with Estrapak-50. | 1994 | Maturitas | pmid:8177092 |
| Posaci C et al. | Effects of HRT on serum levels of IGF-I in postmenopausal women. | 2001 | Maturitas | pmid:11684375 |
| Eilertsen AL et al. | Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation. | 2006 | Maturitas | pmid:16713143 |
| Paterson ME | A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters. | 1982 | Maturitas | pmid:6750325 |
| Lindgren R et al. | Endometrial effects of transdermal estradiol/norethisterone acetate. | 1992 | Maturitas | pmid:1528133 |
| Gambacciani M et al. | Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women. | 2008 | Maturitas | pmid:18063490 |
| Taner MZ et al. | Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study. | 2006 | Maturitas | pmid:15978753 |
| Mattsson LA et al. | Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints. | 1982 | Maturitas | pmid:7121296 |
| Jondet M and Dehennin L | Impact of different progestins on endometrial vascularisation of postmenopausal women. A retrospective image analysis-morphometric study. | 2003 | Maturitas | pmid:14585519 |
| Pata O et al. | The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women. | 2003 | Maturitas | pmid:14585524 |
| Christodoulakos GE et al. | The effect of various regimens of hormone replacement therapy on mammographic breast density. | 2003 | Maturitas | pmid:12787969 |
| Fotherby K | Pharmacokinetics of progestational compounds. | 1986 | Maturitas | pmid:2943973 |